A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
Authors
Keywords
-
Journal
Nature Reviews Neurology
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-04
DOI
10.1038/s41582-018-0116-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease
- (2018) Courtney L. Sutphen et al. Alzheimers & Dementia
- Helicobacter pylori and the risk of dementia: A population-based study
- (2018) Lana Fani et al. Alzheimers & Dementia
- Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults
- (2018) Nancy J. Donovan et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effect of sleep on overnight cerebrospinal fluid amyloid β kinetics
- (2018) Brendan P. Lucey et al. ANNALS OF NEUROLOGY
- Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibition Impairs Synaptic Plasticity via Seizure Protein 6
- (2018) Kaichuan Zhu et al. BIOLOGICAL PSYCHIATRY
- The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease
- (2018) Andre F Batista et al. JOURNAL OF PATHOLOGY
- Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study
- (2018) Brian A Gordon et al. LANCET NEUROLOGY
- Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study
- (2018) Bruno Dubois et al. LANCET NEUROLOGY
- Tau-targeting therapies for Alzheimer disease
- (2018) Erin E. Congdon et al. Nature Reviews Neurology
- Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
- (2018) Steven E. Arnold et al. Nature Reviews Neurology
- ABBY
- (2018) Jeffrey L. Cummings et al. NEUROLOGY
- Tau Kinetics in Neurons and the Human Central Nervous System
- (2018) Chihiro Sato et al. NEURON
- Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
- (2018) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- β-Amyloid accumulation in the human brain after one night of sleep deprivation
- (2018) Ehsan Shokri-Kojori et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease
- (2018) Holly M. Brothers et al. Frontiers in Aging Neuroscience
- Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia
- (2018) Willemijn J. Jansen et al. JAMA Psychiatry
- Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review
- (2018) Christian Benedict et al. Frontiers in Neuroscience
- The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
- (2018) Ulf Neumann et al. EMBO Molecular Medicine
- Gantenerumab: A Novel Human Anti-Aβ Antibody Demonstrates Sustained Cerebral Amyloid-β Binding and Elicits Cell-Mediated Removal of Human Amyloid-β
- (2018) Bernd Bohrmann et al. JOURNAL OF ALZHEIMERS DISEASE
- Is ‘friendly fire’ in the brain provoking Alzheimer’s disease?
- (2018) Alison Abbott NATURE
- Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease
- (2018) Eric McDade et al. NEUROLOGY
- Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer’s disease (BLAZE)
- (2018) Stephen Salloway et al. Alzheimers Research & Therapy
- Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons
- (2017) Michael C. Donohue et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-AβPPswe Mice Without Inducing Microhemorrhage
- (2017) Stephanie Villarreal et al. JOURNAL OF ALZHEIMERS DISEASE
- Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer’s Disease Biomarkers: A Pilot Clinical Trial
- (2017) Suzanne Craft et al. JOURNAL OF ALZHEIMERS DISEASE
- Mechanisms of recognition of amyloid-β (Aβ) monomer, oligomer, and fibril by homologous antibodies
- (2017) Jun Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid Aβ Peptides
- (2017) Kei Sakamoto et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Amyloid-β Peptide Is Needed for cGMP-Induced Long-Term Potentiation and Memory
- (2017) Agostino Palmeri et al. JOURNAL OF NEUROSCIENCE
- Dementia prevention, intervention, and care
- (2017) Gill Livingston et al. LANCET
- Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50–95 years: a cross-sectional study
- (2017) Clifford R Jack et al. LANCET NEUROLOGY
- Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation
- (2017) Zhuohao He et al. NATURE MEDICINE
- Microglia emerge as central players in brain disease
- (2017) Michael W Salter et al. NATURE MEDICINE
- Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies
- (2017) Juan Carlos Polanco et al. Nature Reviews Neurology
- APOE genotype and early β-amyloid accumulation in older adults without dementia
- (2017) Yen Ying Lim et al. NEUROLOGY
- A phase 3 trial of IV immunoglobulin for Alzheimer disease
- (2017) Norman R. Relkin et al. NEUROLOGY
- Amyloid Beta Peptides Block New Synapse Assembly by Nogo Receptor-Mediated Inhibition of T-Type Calcium Channels
- (2017) Yanjun Zhao et al. NEURON
- Reproductive and developmental toxicology studies with gantenerumab in PS2APP transgenic mice
- (2017) Paul Barrow et al. REPRODUCTIVE TOXICOLOGY
- The amyloid-β oligomer Aβ*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation
- (2017) Fatou Amar et al. Science Signaling
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
- (2017) Susanne Ostrowitzki et al. Alzheimers Research & Therapy
- Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden
- (2017) Rachel F. Buckley et al. JAMA Neurology
- The amyloid-β oligomer Aβ*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation
- (2017) Fatou Amar et al. Science Signaling
- Anesthesia with Isoflurane Increases Amyloid Pathology in Mice Models of Alzheimer'S Disease
- (2017) Juan Perucho et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid-β as a Modulator of Synaptic Plasticity
- (2017) Mordhwaj S. Parihar et al. JOURNAL OF ALZHEIMERS DISEASE
- A Physiological Role for Amyloid-β Protein: Enhancement of Learning and Memory
- (2017) John E. Morley et al. JOURNAL OF ALZHEIMERS DISEASE
- Coronary Artery Bypass Surgery Provokes Alzheimer's Disease-Like Changes in the Cerebrospinal Fluid
- (2017) András Palotás et al. JOURNAL OF ALZHEIMERS DISEASE
- Is Brain Amyloid Production a Cause or a Result of Dementia of The Alzheimer's Type?
- (2017) Robert G. Struble et al. JOURNAL OF ALZHEIMERS DISEASE
- PHARMACODYNAMICS OF THE ORAL BACE INHIBITOR JNJ-54861911 IN EARLY ALZHEIMER'S DISEASE
- (2016) Johannes Streffer et al. Alzheimers & Dementia
- RESULTS FROM A FIRST-IN-HUMAN STUDY WITH THE BACE INHIBITOR CNP520
- (2016) Mike Ufer et al. Alzheimers & Dementia
- CLINICAL TRIAL DESIGN OF CREAD: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP PHASE 3 STUDY TO EVALUATE CRENEZUMAB TREATMENT IN PATIENTS WITH PRODROMAL-TO-MILD ALZHEIMER’S DISEASE
- (2016) Thomas Blaettler et al. Alzheimers & Dementia
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer’s Disease
- (2016) Gvido Cebers et al. JOURNAL OF ALZHEIMERS DISEASE
- An Oral Aβ Vaccine Using a Recombinant Adeno-Associated Virus Vector in Aged Monkeys: Reduction in Plaque Amyloid and Increase in Aβ Oligomers
- (2016) Hideo Hara et al. JOURNAL OF ALZHEIMERS DISEASE
- AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics
- (2016) Susanna Eketjäll et al. JOURNAL OF ALZHEIMERS DISEASE
- Two Phase 2 Multiple Ascending–Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer’s Disease
- (2016) Florence Pasquier et al. JOURNAL OF ALZHEIMERS DISEASE
- ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials
- (2016) Jinping Wang et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate
- (2016) Ting Yang et al. JOURNAL OF NEUROSCIENCE
- Immunotherapy with Aducanumab Restores Calcium Homeostasis in Tg2576 Mice
- (2016) Ksenia V. Kastanenka et al. JOURNAL OF NEUROSCIENCE
- Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study
- (2016) Samantha C Burnham et al. LANCET NEUROLOGY
- Failed Alzheimer’s trial does not kill leading theory of disease
- (2016) Alison Abbott et al. NATURE
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- CSF and amyloid pet biomarker data from scarlet road - a global Phase 3 study of gantenerumab in patients with prodromal AD
- (2016) Tania Nikolcheva et al. NEUROBIOLOGY OF AGING
- The adaptive immune system restrains Alzheimer’s disease pathogenesis by modulating microglial function
- (2016) Samuel E. Marsh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The BACE1 inhibitor verubecestat (MK-8931) reduces CNS -amyloid in animal models and in Alzheimers disease patients
- (2016) M. E. Kennedy et al. Science Translational Medicine
- Effect of general anesthesia on serum β-amyloid protein and regional cerebral oxygen saturation of elderly patients after subtotal gastrectomy
- (2016) Peng Yu et al. Experimental and Therapeutic Medicine
- Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody
- (2016) Veronika Logovinsky et al. Alzheimers Research & Therapy
- Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy
- (2016) Liang Wang et al. JAMA Neurology
- Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community
- (2016) Ronald C. Petersen et al. JAMA Neurology
- Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
- (2016) Riqiang Yan Translational Neurodegeneration
- Structure of Crenezumab Complex with Aβ Shows Loss of β-Hairpin
- (2016) Mark Ultsch et al. Scientific Reports
- Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncated Abeta in sporadic Alzheimer disease cases and mouse models
- (2015) Yvonne Bouter et al. ACTA NEUROPATHOLOGICA
- Comparing the efficacy and neuroinflammatory potential of three anti-abeta antibodies
- (2015) James P. Fuller et al. ACTA NEUROPATHOLOGICA
- Beta-amyloid deposition in chronic traumatic encephalopathy
- (2015) Thor D. Stein et al. ACTA NEUROPATHOLOGICA
- Pharmacological Inhibition of BACE1 Impairs Synaptic Plasticity and Cognitive Functions
- (2015) Severin Filser et al. BIOLOGICAL PSYCHIATRY
- The Neuropathology of Chronic Traumatic Encephalopathy
- (2015) Ann C. McKee et al. BRAIN PATHOLOGY
- Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
- (2015) Willemijn J. Jansen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of the inhaled anesthetics isoflurane, sevoflurane and desflurane on the neuropathogenesis of Alzheimer’s disease (Review)
- (2015) JUE JIANG et al. Molecular Medicine Reports
- The Essential Role of Soluble Aβ Oligomers in Alzheimer’s Disease
- (2015) Zi-Xuan Wang et al. MOLECULAR NEUROBIOLOGY
- Decreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer's models
- (2015) Marc Aurel Busche et al. NATURE NEUROSCIENCE
- The case for rejecting the amyloid cascade hypothesis
- (2015) Karl Herrup NATURE NEUROSCIENCE
- Three dimensions of the amyloid hypothesis: time, space and 'wingmen'
- (2015) Erik S Musiek et al. NATURE NEUROSCIENCE
- Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice
- (2015) Alexandra J. Mably et al. NEUROBIOLOGY OF DISEASE
- An Assessment of Possible Neuropathology and Clinical Relationships in 46 Sporadic Amyotrophic Lateral Sclerosis Patient Autopsies
- (2015) Grant Coan et al. Neurodegenerative Diseases
- The keystone of Alzheimer pathogenesis might be sought in Aβ physiology
- (2015) D. Puzzo et al. NEUROSCIENCE
- Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer’s disease
- (2015) Martin R Farlow et al. Alzheimers Research & Therapy
- Targeting Prodromal Alzheimer Disease With Avagacestat
- (2015) Vladimir Coric et al. JAMA Neurology
- CSF amyloid lowering in human volunteers after 14 days’ oral administration of the novel BACE1 inhibitor E2609
- (2014) Bruce Albala et al. Alzheimers & Dementia
- Lessons from a BACE1 inhibitor trial: Off-site but not off base
- (2014) Debomoy K. Lahiri et al. Alzheimers & Dementia
- Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain
- (2014) D. Allan Butterfield et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease
- (2014) F. G. De Felice et al. DIABETES
- Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease
- (2014) M. Yarchoan et al. DIABETES
- A study on the association between infectious burden and Alzheimer's disease
- (2014) X.-L. Bu et al. EUROPEAN JOURNAL OF NEUROLOGY
- Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects
- (2014) Robert Vassar et al. JOURNAL OF NEUROCHEMISTRY
- Regulation of Presynaptic Ca2+, Synaptic Plasticity and Contextual Fear Conditioning by a N-terminal -Amyloid Fragment
- (2014) J. L. M. Lawrence et al. JOURNAL OF NEUROSCIENCE
- Combined Treatment with a BACE Inhibitor and Anti-A Antibody Gantenerumab Enhances Amyloid Reduction in APPLondon Mice
- (2014) H. Jacobsen et al. JOURNAL OF NEUROSCIENCE
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- The A4 Study: Stopping AD Before Symptoms Begin?
- (2014) R. A. Sperling et al. Science Translational Medicine
- The Preclinical Alzheimer Cognitive Composite
- (2014) Michael C. Donohue et al. JAMA Neurology
- Effect of 1 Night of Total Sleep Deprivation on Cerebrospinal Fluid β-Amyloid 42 in Healthy Middle-Aged Men
- (2014) Sharon Ooms et al. JAMA Neurology
- Brain amyloid-β oligomers in ageing and Alzheimer’s disease
- (2013) Sylvain E. Lesné et al. BRAIN
- Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography
- (2013) Kuan-Yi Wu et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Detection of β-amyloid oligomers as a predictor of neurological outcome after brain injury
- (2013) Joshua Wayne Gatson et al. JOURNAL OF NEUROSURGERY
- Monitoring of β-Amyloid Dynamics after Human Traumatic Brain Injury
- (2013) Niklas Marklund et al. JOURNAL OF NEUROTRAUMA
- Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
- (2013) Stephanie JB Vos et al. LANCET NEUROLOGY
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
- (2013) Victor L Villemagne et al. LANCET NEUROLOGY
- Normal cognition in transgenic BRI2-Aβ mice
- (2013) Jungsu Kim et al. Molecular Neurodegeneration
- Aβ-independent processes—rethinking preclinical AD
- (2013) Gaël Chételat Nature Reviews Neurology
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-amyloid brain entry and aggregation
- (2013) Ayman ElAli et al. Acta Neuropathologica Communications
- Open-heart surgery increases cerebrospinal fluid levels of Alzheimer-associated amyloid β
- (2012) B. REINSFELT et al. ACTA ANAESTHESIOLOGICA SCANDINAVICA
- Rational heterodoxy: Cholesterol reformation of the amyloid doctrine
- (2012) Michael A. Castello et al. AGEING RESEARCH REVIEWS
- First-in-human study of E2609, a novel BACE1 inhibitor, demonstrates prolonged reductions in plasma beta-amyloid levels after single dosing
- (2012) Robert Lai et al. Alzheimers & Dementia
- Safety and biomarker effects of solanezumab in patients with Alzheimer’s disease
- (2012) Martin Farlow et al. Alzheimers & Dementia
- Lower CSF Amyloid Beta Peptides and Higher F2-Isoprostanes in Cognitively Intact Elderly Individuals With Major Depressive Disorder
- (2012) Nunzio Pomara et al. AMERICAN JOURNAL OF PSYCHIATRY
- Brain injury biomarkers are not dependent on β-amyloid in normal elderly
- (2012) David S. Knopman et al. ANNALS OF NEUROLOGY
- Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
- (2012) Vladimir Coric et al. ARCHIVES OF NEUROLOGY
- Amyloid precursor protein (APP) contributes to pathology in the SOD1G93A mouse model of amyotrophic lateral sclerosis
- (2012) J. Barney Bryson et al. HUMAN MOLECULAR GENETICS
- Apolipoprotein E, Not Fibrillar -Amyloid, Reduces Cerebral Glucose Metabolism in Normal Aging
- (2012) W. J. Jagust et al. JOURNAL OF NEUROSCIENCE
- An Effector-Reduced Anti- -Amyloid (A ) Antibody with Unique A Binding Properties Promotes Neuroprotection and Glial Engulfment of A
- (2012) O. Adolfsson et al. JOURNAL OF NEUROSCIENCE
- Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
- (2012) Bengt Winblad et al. LANCET NEUROLOGY
- Brain Ischemia Activates β- and γ-Secretase Cleavage of Amyloid Precursor Protein: Significance in Sporadic Alzheimer’s Disease
- (2012) Ryszard Pluta et al. MOLECULAR NEUROBIOLOGY
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
- (2012) Thorlakur Jonsson et al. NATURE
- Deciphering the mechanism underlying late-onset Alzheimer disease
- (2012) Dimitrije Krstic et al. Nature Reviews Neurology
- Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease
- (2012) D. S. Knopman et al. NEUROLOGY
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Is Alzheimer’s disease amyloidosis the result of a repair mechanism gone astray?
- (2011) Tyler A. Kokjohn et al. Alzheimers & Dementia
- Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
- (2011) Paul S. Aisen et al. Archives of Medical Science
- Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
- (2011) Susanne Ostrowitzki ARCHIVES OF NEUROLOGY
- Cerebrovascular lesions induce transient -amyloid deposition
- (2011) M. Garcia-Alloza et al. BRAIN
- Comparison of Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of the Amyloid β Monoclonal Antibody Solanezumab in Japanese and White Patients With Mild to Moderate Alzheimer Disease
- (2011) Kazunori Uenaka et al. CLINICAL NEUROPHARMACOLOGY
- The Second-Generation Active A Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
- (2011) C. Wiessner et al. JOURNAL OF NEUROSCIENCE
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
- (2011) S. Salloway et al. NEUROLOGY
- Hypoxia Due to Cardiac Arrest Induces a Time-Dependent Increase in Serum Amyloid β Levels in Humans
- (2011) Henrik Zetterberg et al. PLoS One
- The pathological process underlying Alzheimer’s disease in individuals under thirty
- (2010) Heiko Braak et al. ACTA NEUROPATHOLOGICA
- Anaesthetics and postoperative cognitive dysfunction: a pathological mechanism mimicking Alzheimer’s disease
- (2010) V. Fodale et al. ANAESTHESIA
- Endogenous amyloid-β is necessary for hippocampal synaptic plasticity and memory
- (2010) Daniela Puzzo et al. ANNALS OF NEUROLOGY
- Safety and Changes in Plasma and Cerebrospinal Fluid Amyloid β After a Single Administration of an Amyloid β Monoclonal Antibody in Subjects With Alzheimer Disease
- (2010) Eric R. Siemers et al. CLINICAL NEUROPHARMACOLOGY
- Reimagining Alzheimer's Disease--An Age-Based Hypothesis
- (2010) K. Herrup JOURNAL OF NEUROSCIENCE
- The biochemical aftermath of anti-amyloid immunotherapy
- (2010) Chera L Maarouf et al. Molecular Neurodegeneration
- Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease?
- (2010) Victoria E. Johnson et al. NATURE REVIEWS NEUROSCIENCE
- Decreased Clearance of CNS -Amyloid in Alzheimer's Disease
- (2010) K. G. Mawuenyega et al. SCIENCE
- Selection of an anti-Abeta antibody that binds various forms of Abeta and blocks toxicity both in vitro and in vivo
- (2009) Ryan J. Watts et al. Alzheimers & Dementia
- Simvastatin therapy prevents brain trauma-induced increases in β-amyloid peptide levels
- (2009) Eric E. Abrahamson et al. ANNALS OF NEUROLOGY
- The Common Inhalational Anesthetic Sevoflurane Induces Apoptosis and Increases β-Amyloid Protein Levels
- (2009) Yuanlin Dong et al. ARCHIVES OF NEUROLOGY
- Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled Trial
- (2009) Robert C. Green JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cognitive impairment in nondiabetic middle-aged and older adults is associated with insulin resistance
- (2009) H. Bruehl et al. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
- A Immunotherapy: Intracerebral Sequestration of A by an Anti-A Monoclonal Antibody 266 with High Affinity to Soluble A
- (2009) K. Yamada et al. JOURNAL OF NEUROSCIENCE
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Amyloid-β as a positive endogenous regulator of release probability at hippocampal synapses
- (2009) Efrat Abramov et al. NATURE NEUROSCIENCE
- S1-02-02: Natural human antibodies targeting amyloid aggregates in intravenous immunoglobulin
- (2008) Norman R. Relkin Alzheimers & Dementia
- Alzheimer Disease Pathology As a Host Response
- (2008) Rudy J. Castellani et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Insulin Receptor Signaling Regulates Synapse Number, Dendritic Plasticity, and Circuit Function In Vivo
- (2008) Shu-Ling Chiu et al. NEURON
- Hypoxia increases Aβ generation by altering β- and γ-cleavage of APP
- (2007) Liang Li et al. NEUROBIOLOGY OF AGING
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now